Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacists | 2 | 2011 | 125 | 0.360 |
Why?
|
| Appetite Depressants | 1 | 2009 | 11 | 0.340 |
Why?
|
| Anti-Obesity Agents | 1 | 2009 | 42 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 1085 | 0.310 |
Why?
|
| Quality Improvement | 1 | 2011 | 413 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 529 | 0.270 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 188 | 0.270 |
Why?
|
| Primary Health Care | 2 | 2011 | 703 | 0.260 |
Why?
|
| Antiparkinson Agents | 1 | 2005 | 34 | 0.260 |
Why?
|
| Dopamine Agonists | 1 | 2005 | 68 | 0.250 |
Why?
|
| Dyspepsia | 1 | 2004 | 8 | 0.240 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 51 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2007 | 310 | 0.230 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 78 | 0.230 |
Why?
|
| Physicians | 1 | 2007 | 324 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 1 | 2004 | 107 | 0.220 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2005 | 189 | 0.220 |
Why?
|
| Premenstrual Syndrome | 1 | 2003 | 4 | 0.220 |
Why?
|
| Parkinson Disease | 1 | 2005 | 272 | 0.210 |
Why?
|
| Obesity | 1 | 2009 | 1076 | 0.200 |
Why?
|
| Brain Ischemia | 1 | 2007 | 665 | 0.200 |
Why?
|
| Metoprolol | 1 | 2000 | 8 | 0.180 |
Why?
|
| Carbazoles | 1 | 2000 | 46 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2003 | 362 | 0.180 |
Why?
|
| Propanolamines | 1 | 2000 | 70 | 0.170 |
Why?
|
| Insulin | 1 | 2003 | 619 | 0.170 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 138 | 0.170 |
Why?
|
| Program Evaluation | 2 | 2011 | 502 | 0.140 |
Why?
|
| Hypertension | 1 | 2005 | 1535 | 0.130 |
Why?
|
| Stroke | 1 | 2007 | 2163 | 0.120 |
Why?
|
| Humans | 12 | 2011 | 68618 | 0.110 |
Why?
|
| Heart Failure | 1 | 2000 | 1180 | 0.100 |
Why?
|
| Adrenergic Agents | 1 | 2009 | 14 | 0.080 |
Why?
|
| Serotonin Agents | 1 | 2009 | 13 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2011 | 340 | 0.080 |
Why?
|
| Anticholesteremic Agents | 1 | 1998 | 49 | 0.080 |
Why?
|
| Aged | 4 | 2011 | 14862 | 0.080 |
Why?
|
| Lovastatin | 1 | 1998 | 78 | 0.080 |
Why?
|
| Chickenpox Vaccine | 1 | 1997 | 5 | 0.080 |
Why?
|
| Chickenpox | 1 | 1997 | 14 | 0.080 |
Why?
|
| Hematologic Agents | 1 | 2007 | 11 | 0.070 |
Why?
|
| Organizational Innovation | 1 | 2007 | 55 | 0.070 |
Why?
|
| Herpes Zoster | 1 | 1997 | 43 | 0.070 |
Why?
|
| Organizational Objectives | 1 | 2007 | 70 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2011 | 374 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 91 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2007 | 97 | 0.070 |
Why?
|
| Cholesterol | 1 | 1998 | 331 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2007 | 83 | 0.070 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 110 | 0.070 |
Why?
|
| Endarterectomy, Carotid | 1 | 2007 | 110 | 0.070 |
Why?
|
| Coronary Disease | 1 | 1998 | 358 | 0.070 |
Why?
|
| Program Development | 1 | 2007 | 240 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2007 | 291 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2009 | 867 | 0.060 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 233 | 0.060 |
Why?
|
| Systole | 1 | 2005 | 149 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2005 | 138 | 0.060 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 152 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 202 | 0.060 |
Why?
|
| Psychotropic Drugs | 1 | 2004 | 83 | 0.060 |
Why?
|
| Female | 5 | 2011 | 38074 | 0.060 |
Why?
|
| Stents | 1 | 2007 | 657 | 0.050 |
Why?
|
| Life Style | 1 | 2005 | 338 | 0.050 |
Why?
|
| Hypoglycemia | 1 | 2003 | 72 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 567 | 0.050 |
Why?
|
| Inpatients | 1 | 2003 | 208 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2003 | 158 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4848 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 848 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 498 | 0.050 |
Why?
|
| Male | 4 | 2011 | 37321 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2000 | 57 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2000 | 2077 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 772 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2003 | 631 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1140 | 0.040 |
Why?
|
| Length of Stay | 1 | 2003 | 780 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 5717 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2800 | 0.040 |
Why?
|
| Adult | 2 | 2011 | 21403 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 172 | 0.040 |
Why?
|
| Comorbidity | 1 | 2003 | 1426 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2004 | 659 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2011 | 7277 | 0.040 |
Why?
|
| United States | 2 | 2007 | 7367 | 0.040 |
Why?
|
| Middle Aged | 3 | 2005 | 21147 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 1026 | 0.040 |
Why?
|
| Risk Factors | 1 | 2007 | 5731 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2003 | 3705 | 0.030 |
Why?
|
| Hospitalization | 1 | 2000 | 978 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 1998 | 50 | 0.020 |
Why?
|
| Contraindications | 1 | 1997 | 52 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1998 | 141 | 0.020 |
Why?
|
| Acute Disease | 1 | 1998 | 658 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1997 | 403 | 0.020 |
Why?
|
| Family Practice | 1 | 1997 | 312 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1998 | 1738 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 931 | 0.010 |
Why?
|
| Pediatrics | 1 | 1997 | 341 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1998 | 807 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1998 | 7029 | 0.010 |
Why?
|